These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37863663)
21. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract. Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409 [TBL] [Abstract][Full Text] [Related]
22. Hypericum perforatum (St John's wort) beyond depression: A therapeutic perspective for pain conditions. Galeotti N J Ethnopharmacol; 2017 Mar; 200():136-146. PubMed ID: 28216196 [TBL] [Abstract][Full Text] [Related]
23. St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrier. El Biali M; Wölfl-Duchek M; Jackwerth M; Mairinger S; Weber M; Bamminger K; Poschner S; Rausch I; Schindler N; Lozano IH; Jäger W; Nics L; Tournier N; Hacker M; Zeitlinger M; Bauer M; Langer O Clin Transl Sci; 2024 May; 17(5):e13804. PubMed ID: 38700454 [TBL] [Abstract][Full Text] [Related]
24. Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A activity. Fuchs I; Hafner-Blumenstiel V; Markert C; Burhenne J; Weiss J; Haefeli WE; Mikus G Eur J Clin Pharmacol; 2013 Mar; 69(3):507-13. PubMed ID: 22968811 [TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of St. John's wort drug interactions revisited. Nicolussi S; Drewe J; Butterweck V; Meyer Zu Schwabedissen HE Br J Pharmacol; 2020 Mar; 177(6):1212-1226. PubMed ID: 31742659 [TBL] [Abstract][Full Text] [Related]
26. Hyperforin in St. John's wort drug interactions. Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V Eur J Clin Pharmacol; 2006 Mar; 62(3):225-33. PubMed ID: 16477470 [TBL] [Abstract][Full Text] [Related]
27. The time-dependent effects of St John's wort on cytochrome P450, uridine diphosphate-glucuronosyltransferase, glutathione S-transferase, and NAD(P)H-quinone oxidoreductase in mice. Yang JF; Liu YR; Huang CC; Ueng YF J Food Drug Anal; 2018 Jan; 26(1):422-431. PubMed ID: 29389584 [TBL] [Abstract][Full Text] [Related]
28. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin. Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409 [TBL] [Abstract][Full Text] [Related]
29. Effect of Tacrolimus Formulation (Prolonged-Release vs Immediate-Release) on Its Susceptibility to Drug-Drug Interactions with St. John's Wort. Gümüs KS; Teegelbekkers A; Sauter M; Meid AD; Burhenne J; Weiss J; Blank A; Haefeli WE; Czock D Clin Pharmacol Drug Dev; 2024 Mar; 13(3):297-306. PubMed ID: 38176912 [TBL] [Abstract][Full Text] [Related]
30. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019 [TBL] [Abstract][Full Text] [Related]
31. Drug interactions with St John's wort : mechanisms and clinical implications. Mannel M Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151 [TBL] [Abstract][Full Text] [Related]
32. The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver. Dostalek M; Pistovcakova J; Jurica J; Sulcova A; Tomandl J Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):253-7. PubMed ID: 22286810 [TBL] [Abstract][Full Text] [Related]
33. Hyperforin-containing extracts of St John's wort fail to alter gene transcription in brain areas involved in HPA axis control in a long-term treatment regimen in rats. Butterweck V; Winterhoff H; Herkenham M Neuropsychopharmacology; 2003 Dec; 28(12):2160-8. PubMed ID: 12865894 [TBL] [Abstract][Full Text] [Related]
34. Optimization of Light Intensity, Temperature, and Nutrients to Enhance the Bioactive Content of Hyperforin and Rutin in St. John's Wort. Kuo CH; Chou YC; Liao KC; Shieh CJ; Deng TS Molecules; 2020 Sep; 25(18):. PubMed ID: 32948004 [TBL] [Abstract][Full Text] [Related]
35. Dexamethasone transcriptionally increases the expression of the pregnane X receptor and synergistically enhances pyrethroid esfenvalerate in the induction of cytochrome P450 3A23. Shi D; Yang D; Yan B Biochem Pharmacol; 2010 Oct; 80(8):1274-83. PubMed ID: 20599767 [TBL] [Abstract][Full Text] [Related]
36. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747 [TBL] [Abstract][Full Text] [Related]
37. St. John's Wort Exacerbates Acetaminophen-Induced Liver Injury by Activation of PXR and CYP-Mediated Bioactivation. Jiang Y; Zhou Y; Song S; Fan S; Gao Y; Li Y; Huang M; Bi H Toxicol Sci; 2022 Oct; 190(1):54-63. PubMed ID: 36073954 [TBL] [Abstract][Full Text] [Related]
38. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort. Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454 [TBL] [Abstract][Full Text] [Related]
39. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991 [TBL] [Abstract][Full Text] [Related]
40. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line. Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]